The increasing burden of cancer and ophthalmic disorders is creating substantial demand for advanced therapeutic solutions worldwide. Anti-angiogenic therapies have become an important component of modern treatment strategies, particularly in oncology and retinal disease management. Continuous innovation in targeted therapies is further supporting industry expansion across developed and...